skinny.

Latest / Neurology® Podcast

ARIA Associated with Aducanumab

Dr. Jeff Burns talks with Dr. Lon Schneider about the development of ARIA in the Phase 3 EMERGE and ENGAGE trials that led to the FDA's accelerated approval of aducanumab for the treatment of Alzheimer disease.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.